ADARx
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
5871 Oberlin Dr Ste 200, San Diego, Cali...Phone Number
(877) 232-7974Website
www.adarx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
1
1
2
2
1
About ADARx
ADARx Pharmaceuticals is a San Diego, California-based late-stage clinical biotechnology company founded in 2019 that develops next-generation RNA medicines using proprietary RNA-targeted therapies. The company is advancing a pipeline of selective and durable candidates targeting complement-mediated, genetic, cardiovascular, thrombotic, central nervous system, and metabolic diseases. ADARx was founded by Zhen Li, who serves as President and CEO, and has partnered with AbbVie to expand its siRNA technology into neuroscience, immunology, and oncology.Explore more
ADARx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is ADARx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once ADARx has new funding data
ADARx, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if ADARx has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at ADARx
Click to see if ADARx had a recent Job posting/layoffs
Product Launch: Get notified when ADARx launches new products
Check out if ADARx is spiking on competitors!
Earning: See what the market has to say on ADARx recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to ADARx
Compare insights from companies similar to ADARx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
ADARx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
ADARx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about ADARx.
ADARx financials insights
Gather financial insights about ADARx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Unspecified
$5M
Unspecified
$6M
2023
Series B
$75M
Series C
$200M
ADARx Tech Stack
A closer look at the technologies used by ADARx
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
ADARx News & Media
ADARx Pharmaceuticals Expands Leadership Team with Board and Executive Appointments
ADARx is expanding its leadership team with Dr. Ying Huang to BOD and Rob Ackles as Chief People Officer as company advances its siRNA clinical programs.ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress
ADARx to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI CongressADARx Pharmaceuticals Expands Leadership Team with Appointment of Healthcare Investment Banking Veteran Ryan Fisk as Chief Financial Officer and Chief Business Officer
ADARx Pharmaceuticals Expands Leadership Team with Appointment of Healthcare Investment Banking Veteran Ryan Fisk as CFO and CBOADARx Pharmaceuticals Presents Onvuzosiran Data Supporting Potential for Sustained Attack-Free Rates with Reduced Treatment Burden in Patients with HAE
– Onvuzosiran achieved significant and durable reductions of plasma kallikrein levels with a favorable safety profile in Phase 1/2 –
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding ADARx
Sign Up For FreeTo access detailed company insights
ADARx Pharmaceuticals is a San Diego, California-based late-stage clinical biotechnology company founded in 2019 that develops next-generation RNA medicines using proprietary RNA-targeted therapies. The company is advancing a pipeline of selective and durable candidates targeting complement-mediated, genetic, cardiovascular, thrombotic, central ner... Read More
